Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41467-018-06981-w
Title: Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery
Authors: Than, A
Liu, C
Chang, H
Duong, P.K
Cheung, C.M.G 
Xu, C
Wang, X
Chen, P
Keywords: diclofenac
eye drops
hyaluronic acid
immunoglobulin G
interleukin 6
monoclonal antibody DC101
vasculotropin inhibitor
drug
vasculotropin A
antibody
array
drug
eye disease
injury
reaction kinetics
animal experiment
animal model
antiangiogenic activity
Article
confocal microscopy
controlled study
cornea disease
cornea neovascularization
drug delivery system
drug megadose
drug potentiation
drug safety
drug solubility
ex vivo study
human
human tissue
male
microtechnology
molecular weight
mouse
nonhuman
pig
polyacrylamide gel electrophoresis
proof of concept
scanning electron microscopy
sustained drug release
topical treatment
treatment outcome
animal
antagonists and inhibitors
delayed release formulation
drug effect
eye
inflammation
metabolism
needle
pathology
prostheses and orthoses
Animals
Delayed-Action Preparations
Drug Delivery Systems
Eye
Inflammation
Mice
Needles
Pharmaceutical Preparations
Prostheses and Implants
Sus scrofa
Vascular Endothelial Growth Factor A
Issue Date: 2018
Publisher: Nature Publishing Group
Citation: Than, A, Liu, C, Chang, H, Duong, P.K, Cheung, C.M.G, Xu, C, Wang, X, Chen, P (2018). Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery. Nature Communications 9 (1) : 4433. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-018-06981-w
Rights: Attribution 4.0 International
Abstract: Eye diseases and injuries impose a significant clinical problem worldwide. Safe and effective ocular drug delivery is, however, challenging due to the presence of ocular barriers. Here we report a strategy using an eye patch equipped with an array of detachable microneedles. These microneedles can penetrate the ocular surface tissue, and serve as implanted micro-reservoirs for controlled drug delivery. The biphasic drug release kinetics enabled by the double-layered micro-reservoirs largely enhances therapeutic efficacy. Using corneal neovascularization as the disease model, we show that delivery of an anti-angiogenic monoclonal antibody (DC101) by such eye patch produces ~90% reduction of neovascular area. Furthermore, quick release of an anti-inflammatory compound (diclofenac) followed by a sustained release of DC101 provides synergistic therapeutic outcome. The eye patch application is easy and minimally invasive to ensure good patient compliance. Such intraocular drug delivery strategy promises effective home-based treatment of many eye diseases. © 2018, The Author(s).
Source Title: Nature Communications
URI: https://scholarbank.nus.edu.sg/handle/10635/178384
ISSN: 2041-1723
DOI: 10.1038/s41467-018-06981-w
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41467-018-06981-w.pdf6.57 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons